Latest receivables for MDXG: $46M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Mimedx Group (MDXG) currently reports a receivables of $46M as of March 2026. That compares with $62M in the prior-year period — down 26.1% year over year. Use the charts on this page to explore Mimedx Group's receivables history and peer comparisons.
Mimedx Group's receivables decreased from $62M to $46M — a 26.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Mimedx Group reported $46M in receivables as of March 2026. That compares with $62M in the prior-year period — down 26.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $46M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mimedx Group, and consider following MDXG for alerts when major investors trade the stock.
Mimedx Group is classified in the Industrials sector. On receivables, it currently shows $46M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing MDXG with unrelated industries.